컨텐츠바로가기

KIDS-APECPharmacovigilance CoE Training

About KIDS

Home Overview About KIDS

Legal Basis

Legal basis

Article 68-3 of 「Pharmaceutical Affairs Act」

Establishment on

06 Jan 2012 (Designated as public institution: 31 Jan 2013)

Main business
  • To investigate ADR causality, such as medication accidents
  • To collectㆍanalyzeㆍassessㆍmanage and provide drug safety information
  • To engage in investigationㆍresearch and training: promotion for development/use of drug safety information
  • ADR relief program
  • To collectㆍmanageㆍinvestigateㆍuse and provide the reported information in connection with the handlingㆍmanagement of narcotics
  • To engage in researchㆍtraining and promotion regarding the standardization of narcotics information

Mission and Vision

Mission:To improve public health through drug safety management, Vision:
To be a world leading research institute of drug safety & risk management

Organization Chart

organization
  • President
  • Office of Audit
    • Department of Strategic Management
      Office of Strategic Planning
      Office of Management Support
      Office of Informatization
      Task Force of Integrated Pharmaceutical Information System
    • DDepartment of Drug Safety Information
      Office of Drug Safety Information
      Office of Pharmacoepidemiology and Big Data Analytics
      Office of Drug Utilization Review
      Task Force of Education and Research
    • Department of ADR Relief
      Office of ADR Relief Investigation
      Office of ADR Relief Administration
    • Department of Narcotics Information Management
      Office of Narcotics Information Management
      Office of Narcotics System Development
      Office of Narcotics Reporting Assistance
      Task Force of Narcotics Information Analytics

History

  • 2020
    • 09.23Designated as the Regulatory Science Center for Advanced Therapy Medicinal Products
    • 07.09Excellence Award from the Ministry of Food and Drug Safety’s Business Performance
    • 03.16Excellence Award from the Ministry of Food and Drug Safety’s Corruption Prevention Policy
  • 2019
    • 12.06Operation of the “Integrated Pharmaceutical Information System”
    • 11.11Excellence Award from the Ministry of Food and Drug Safety’s
      Innovative Public Institution Competition
  • 2018
    • 12.032018 Safety Culture Excellence Award (citation from the Minister of the Interior and Safety)
    • 07.253rd President Soon Young Han inauguration
    • 05.25WHO United Arab Amirates(UAE) Health Foundation Prize
    • 05.18Implementation of Reporting on Narcotics Handing System
  • 2017
    • 08.18Endorsement as formal APEC PV Center of Excellence(CoE)
    • 04.145th anniversary ceremony and symposium
  • 2016
    • 09.06Operation of APEC PV Center of Excellence(CoE) Pilot Program
  • 2015
    • 07.20Designated as a Center for Narcotics Information Management
    • 02.132nd President Bon Ki Koo inauguration
  • 2014
    • 12.19Korea ADR Relief program was launched
    • 10.10Designated as a PV training center
    • 08.20Collection of foreign adverse event reports
  • 2013
    • 04.171st anniversary symposium
    • 01.31Designated as public institution
  • 2012
    • 11.01ADR call center established
    • 10.01Establishment of KAERS to receive adverse event reports and collection of local ADR cases
    • 04.17Opening ceremony and symposium
    • 02.061st President Byung Joo Park inauguration
    • 01.06Establishment of Korea Institute of Drug Safety and Risk Management

Location

Korea Institute of Drug Safety and Risk Management Address :

4-6th Fl., 30, Burim-ro 169beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Republic of Korea (For more information, visit www.drugsafe.or.kr)

2020 KIDS-APEC PV CoE Training